Explore
Learn about the evidence, options, and questions to discuss with your clinical team.
Physician-Guided Weight Management
Medical weight loss combines physician evaluation, nutrition and activity guidance, and medication when appropriate. At LavION Health in Phoenix, your health history and goals guide the next step—not a promise of a prescription or a particular result.
Treatment requires evaluation by a licensed provider. Eligibility is determined by a physician. Individual results vary.
01 / Understanding Your Options
What is medical weight management?
Medical weight management is a physician-guided approach to weight-related goals that considers the whole person. It can include behavioral support, nutrition, physical activity, and prescription medication when clinically appropriate. The aim is an individualized, monitored plan, rather than a short-term diet or a medication chosen without an evaluation.
Body weight is influenced by biology, appetite regulation, sleep, medications, environment, and everyday routines. Understanding those factors helps a physician assess whether a medical weight-loss program is appropriate and which options deserve discussion. A consultation should create room for your questions, previous experiences, and priorities, without treating a number on the scale as the complete picture of your health.
GLP-1 receptor agonists act on pathways involved in appetite, food intake, and blood sugar regulation. Semaglutide belongs to this class. Tirzepatide acts on both GIP and GLP-1 receptors. These medications are not interchangeable, and a product approved for one indication is not automatically appropriate for another. Your provider considers the exact medication, indication, formulation, and labeling alongside your individual circumstances.
Medication does not replace the foundations of a sustainable plan. Discuss a realistic eating pattern, adequate protein, hydration, and resistance activity that fits your abilities. During weight loss, preserving strength and lean tissue deserves attention. If appetite changes make it difficult to eat enough, or exercise is limited by pain or other concerns, tell your clinician rather than trying to manage everything alone.
Follow-up gives you and your provider an opportunity to review tolerability, progress, nutrition, and whether the plan needs to change. Dose adjustments, laboratory testing, referrals, and medication continuation are clinical decisions—not automatic steps. LavION Health is a physician-guided medical wellness practice based in Phoenix, Arizona, led by Medical Director Dr. Keith Johnson. Patients in Scottsdale, Paradise Valley, Arcadia, and the greater Phoenix area can ask about appropriate local or telehealth options; availability depends on clinical needs and provider licensure.
02 / Treatment Options
A closer look at
your options.
Information first. Individual evaluation always.
Availability and suitability require clinical confirmation.
01
Semaglutide
Semaglutide is a GLP-1 receptor agonist. Certain FDA-approved semaglutide products have weight-management indications; others have different indications. The medication influences appetite-related signaling and slows gastric emptying. The injectable weight-management product is generally used once weekly with a gradual dose-escalation schedule determined by the prescribing clinician. Eligibility requires more than an interest in losing weight.
Your physician reviews relevant health conditions, current medications, prior weight-management efforts, pregnancy plans, and product-specific warnings. Common gastrointestinal effects include nausea, vomiting, diarrhea, and constipation. Your provider should explain what to do if symptoms affect hydration or eating, and when urgent assessment is needed. If a compounded version is considered, its clinical and legal appropriateness must be discussed separately. Compounded semaglutide is not an FDA-approved product and is not established as interchangeable with an approved brand.
02
Tirzepatide
Tirzepatide acts on GIP and GLP-1 receptors involved in appetite and metabolic signaling. Its FDA-approved products have specific indications, including chronic weight management for an eligible population. An injectable weight-management regimen is generally once weekly, with an initial dose and subsequent adjustments guided by the prescriber and the product label. A higher dose is not automatically a better choice for an individual.
A physician considers your health history, medications, tolerability, and the monitoring you may need before recommending it. Gastrointestinal side effects can occur, and oral contraceptive effectiveness can be affected around initiation and dose increases; discuss label-specific precautions with your provider. Study results help inform a conversation but do not predict your response. If a compounded formulation is discussed, understand that it is not FDA-approved and has not undergone FDA review for safety, effectiveness, or quality. Do not buy a product solely because its ingredient name resembles an approved medication.
03
Personalized Weight Management Programs
A personalized weight-management program starts with your goals and a physician assessment rather than a preselected medication. Some people may benefit from a medication discussion; others may need nutrition support, a different medical evaluation, or a non-medication approach. Your provider can consider appetite patterns, sleep, previous plans, barriers to activity, and the practicality of ongoing follow-up when shaping a recommendation.
An appropriate plan also addresses what happens between visits. That can mean discussing food quality, sufficient protein, strength-preserving movement, hydration, and how to raise concerns about side effects. The frequency and format of follow-up depend on the service and your needs. Ask which visits, tests, support, and medication costs are included before agreeing to a program. There is no universal package or guaranteed outcome; the approved plan should make your responsibilities, the clinician’s role, and your next review clear.
03 / Individual Eligibility
Is this right
for you?
Eligibility often involves BMI, weight-related conditions, prior efforts, and medication-specific criteria. Approved weight-management indications commonly include adults with obesity or overweight with a qualifying weight-related condition. The physician determines whether those criteria, the risks, and the available alternatives support treatment for you.
A conversation may be appropriate if…
Adults seeking a medical evaluation of weight-management options.
People ready to discuss nutrition, activity, and follow-up alongside medication.
Patients who want a plan informed by their history and current medications.
Pause and discuss with a physician if…
Do not begin weight-loss medication during pregnancy; discuss pregnancy planning and breastfeeding with your physician.
Certain products are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2.
People with significant symptoms or complex medical concerns may need another evaluation before pursuing a program.
How It Works
A Clear, Physician-Guided Process
A considered next step. At every stage.
Qualiphy Assessment
Complete medical intake securely through Qualiphy. An assessment does not guarantee a prescription.
Physician Review
A licensed physician considers eligibility, risks, alternatives, and whether additional evaluation is needed.
Your Plan & Ongoing Support
Clarify the appropriate next step and any follow-up or monitoring. A recommendation may be not to proceed.
The Care Experience
What’s included?
These are elements to clarify with your team. Confirm the actual program scope, pricing, and any separate fees before proceeding.
Clinical evaluation
Review of the information needed to determine an appropriate next step through the designated clinical intake.
Individualized recommendations
A discussion of suitable options, alternatives, and the role of nutrition and activity.
Safety guidance
Medication-specific precautions and guidance on communicating side effects if treatment is approved.
Follow-up planning
Clarification of monitoring, adjustments, and ongoing support within your agreed program.
An Informed Perspective
How do semaglutide and tirzepatide compare?
Semaglutide targets GLP-1 receptors; tirzepatide targets both GIP and GLP-1 receptors. Both have once-weekly injectable weight-management products, but they differ in labeling, precautions, and individual tolerability. The studies below involved different populations and designs, so these figures are not a head-to-head comparison or a promised outcome.
| Consideration | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | GIP and GLP-1 receptor agonist |
| Injectable weight-management dosing | Generally once weekly; clinician-directed escalation | Generally once weekly; clinician-directed escalation |
| Published trial findings | STEP 1: mean weight change −14.9% vs −2.4% with placebo at 68 weeks. | SURMOUNT-1: mean change −15.0%, −19.5%, and −20.9% across doses vs −3.1% with placebo at 72 weeks. |
| Common side effects | Nausea, vomiting, diarrhea, constipation | Nausea, vomiting, diarrhea, constipation |
| Selection | Depends on indication, history, risks, and tolerability | Depends on indication, history, risks, and tolerability |
Trial figures refer to studied products in selected adults, alongside lifestyle intervention. They do not establish outcomes for compounded formulations. See STEP 1 and SURMOUNT-1 in the sources below.
Safety & Clinical Judgment
What should you know before proceeding?
Gastrointestinal symptoms are common with GLP-1-based medications, particularly during dose escalation. Persistent vomiting, inability to keep fluids down, or severe abdominal pain needs prompt medical assessment. Product warnings address concerns including pancreatitis, gallbladder problems, dehydration-related kidney injury, and serious allergic reactions. Low blood sugar risk may increase when combined with certain diabetes medications.
Your clinician should review personal and family history, pregnancy considerations, planned procedures, and every medication or supplement you use. Tell the team performing anesthesia or sedation if you take these medications because delayed stomach emptying may matter. Do not change a dose, combine products, or stop prescribed treatment without individualized advice.
Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or quality before marketing. Compounding must satisfy applicable requirements; availability is not a reason to assume appropriateness. FDA has warned about dosing errors and unapproved GLP-1 products, including semaglutide salt forms. Confirm the prescribed formulation, concentration, pharmacy, and measuring instructions with your clinical team.
Sources & further reading
Medical Leadership
Dr. Keith Johnson
LavION Health Medical Director · [BIO PENDING APPROVAL]
Patient & Event Perspectives
Care, in their own words.
I've looked into weight-management programs before, and so many of them seemed to jump straight to a product. What stood out about the LavION Health approach was the emphasis on my health history, my actual goals, and what would be realistic in everyday life. I liked being able to ask questions without feeling pushed toward a specific answer. The focus on physician review and a plan that makes sense for the individual made the whole process feel more thoughtful.
Trying to understand medical weight-loss options on your own can get confusing fast. I had questions about eligibility, appointments, and what happens after an initial assessment. What I liked most was how clearly the steps were explained. There wasn't a promise of some overnight transformation, just a straightforward explanation of how a physician evaluates the options and what appropriate follow-up could look like. That was the kind of clarity I was looking for.
I had been reading about peptides for months, but every website seemed to claim something different. It was refreshing to find an approach that takes the questions seriously and doesn't pretend every peptide is right for every goal. I wanted to understand the evidence, possible risks, and what a physician would actually consider before recommending anything. The emphasis on getting informed first was a big part of what made LavION Health stand out to me.
I came in curious but also a little skeptical, which I think is fair with how much noise there is around wellness treatments. What impressed me was the measured tone. The focus was on understanding my questions, explaining why a medical evaluation matters, and acknowledging that an injectable treatment isn't automatically the right next step. That kind of straightforward communication goes a long way when you're trying to make a decision about your health.
Regenerative medicine is one of those subjects where it's easy to find dramatic claims and much harder to find a balanced explanation. I was interested in learning more, but I didn't want anyone promising a result before understanding my situation. I liked that LavION Health frames this as an educational, physician-guided conversation. Being able to ask about the science, regulatory limitations, and whether further evaluation even makes sense is far more useful to me than hearing another miracle story.
I wasn't looking for a quick fix. I wanted to better understand what people mean when they talk about regenerative medicine and how to separate established information from speculation. The LavION Health approach caught my attention because it leaves room for those important conversations. Instead of treating a consultation like a guaranteed path to treatment, it puts physician judgment, honest explanations, and realistic expectations at the center. That's exactly how a health-related discussion should feel.
When we started planning a golf event, we wanted to bring in something that would feel fresh without being out of place at the club. The LavION Health concierge wellness concept appealed to us because it starts with the audience and the setting rather than a standard package. I especially liked the attention to customization, guest experience, and communication around the details. For a tournament or member gathering, having a wellness element that feels intentional makes a difference.
For a corporate event, we wanted something more interesting than another branded table or giveaway. What drew us to LavION Health was the ability to discuss a wellness experience around the type of guests attending, the atmosphere, and what we wanted the day to feel like. The concept is flexible enough for a professional group without losing that premium, personal touch. It feels like the kind of experience people would actually stop to explore and remember.
Treatment requires evaluation by a licensed provider. Eligibility is determined by a physician. Individual results vary.
Your Questions, Answered
Medical Weight Management
FAQs
Clear answers for a considered decision.
What is medical weight loss in Phoenix?
Medical weight loss is a physician-guided plan that may combine nutrition, activity, behavioral support, and medication when appropriate. LavION Health in Phoenix begins with clinical evaluation. The right approach depends on your history, goals, and risks, not a guarantee that you will receive semaglutide or tirzepatide.
How do I know whether I qualify for a GLP-1 weight loss program?
A physician determines eligibility using the medication’s indication, your health history, weight-related conditions, and potential contraindications. An online assessment supplies information for that decision; it does not approve treatment by itself. Some people need additional evaluation or a different approach.
Is semaglutide the same as tirzepatide?
No. Semaglutide acts on GLP-1 receptors, while tirzepatide acts on GIP and GLP-1 receptors. Both have specific approved products and indications. Their precautions, dosing schedules, and suitability should be discussed with a physician rather than choosing based only on published weight-loss averages.
How quickly will I lose weight?
There is no guaranteed amount or timeline. Response depends on the plan, tolerability, health circumstances, and ongoing habits. Published studies describe group averages, not personal predictions. Your clinician can explain realistic expectations and how progress will be reviewed.
What side effects should I ask about?
Ask about nausea, vomiting, diarrhea, constipation, and medication-specific serious warnings. Also ask how to report symptoms and when to seek urgent help. Your provider should review interactions, pregnancy considerations, and other factors that may make a medication unsuitable.
Why do protein and resistance activity matter during weight loss?
Adequate nutrition and appropriate resistance activity can support strength and lean tissue during weight loss. Needs differ, particularly when appetite is reduced or medical conditions affect eating and exercise. Ask your clinician for an individualized approach rather than using a universal protein target or exercise plan.
Are compounded weight-loss medications FDA-approved?
No. Compounded medications do not undergo FDA approval for safety, effectiveness, or quality. A compounded product should only be considered when clinically appropriate and legally permissible. It is not automatically equivalent to an approved brand, even when the ingredient name looks similar.
Can I use telehealth for medical weight management?
Telehealth may be appropriate depending on your location, provider licensure, and clinical needs. Some patients need in-person assessment or testing. Ask the team about current availability for Phoenix, Scottsdale, Paradise Valley, Arcadia, and your state before assuming a program can be delivered remotely.
How much does a program cost, and what happens at follow-up?
Contact LavION Health for current program details and pricing. Confirm whether evaluation, medication, testing, and follow-up are included or separate. Follow-up may review tolerability, nutrition, progress, and dose decisions; its timing and format depend on the approved plan.
Continue Exploring
A broader view
of your options.
Your Next Chapter
A conversation.
A considered next step.
Treatment requires evaluation by a licensed provider. Eligibility is determined by a physician. Individual results vary.